<?xml version="1.0" encoding="UTF-8"?>
<ref id="jog14384-bib-0020">
 <label>20</label>
 <mixed-citation publication-type="journal" id="jog14384-cit-0020">
  <string-name>
   <surname>Sallard</surname>
   <given-names>E</given-names>
  </string-name>, 
  <string-name>
   <surname>Lescure</surname>
   <given-names>FX</given-names>
  </string-name>, 
  <string-name>
   <surname>Yazdanpanah</surname>
   <given-names>Y</given-names>
  </string-name>, 
  <string-name>
   <surname>Mentre</surname>
   <given-names>F</given-names>
  </string-name>, 
  <string-name>
   <surname>Peiffer‐Smadja</surname>
   <given-names>N</given-names>
  </string-name>. 
  <article-title>Type 1 interferons as a potential treatment against COVID‐19</article-title>. 
  <source xml:lang="en">Antiviral Res</source>
  <year>2020</year>; 
  <volume>178</volume>: 
  <elocation-id>104791</elocation-id>.
  <pub-id pub-id-type="pmid">32275914</pub-id>
 </mixed-citation>
</ref>
